DOCSLIB.ORG

Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi’S Sarcoma and a Subset of Angiosarcomas Harriette J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi’S Sarcoma and a Subset of Angiosarcomas Harriette J Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi’s Sarcoma and a Subset of Angiosarcomas Harriette J. Kahn, M.D., Denis Bailey, M.D., Alexander Marks, M.D. Department of Pathology, Women’s College Campus, Sunnybrook and Women’s College Health Sciences Centre (HJK, AM); Department of Pathology (DB), University Health Network, Banting; and Best Department of Medical Research (AM), University of Toronto, Toronto, Canada omas, in which staining was absent. We conclude that There is controversy over the histogenesis of Kaposi’s D2-40 is a new selective marker of lymphatic endo- sarcoma (KS) from lymphatic or blood vessel endo- thelium in normal tissues and vascular lesions and is thelium. D2-40 is a novel monoclonal antibody to an valuable for studying benign and malignant vascular Mr 40,000 O-linked sialoglycoprotein that reacts with disorders in routinely processed tissue specimens. a fixation-resistant epitope on lymphatic endothe- lium. We sought to establish the selectivity of D2-40 KEY WORDS: Kaposi’s sarcoma, Lymphatic endo- for lymphatic endothelium in normal tissues and thelium, Monoclonal antibody, Vascular lesions. compare its reactivity with the expression of the Mod Pathol 2002;15(4):434–440 widely used vascular endothelial marker CD31 in a series of 62 formalin-fixed and paraffin-embedded Kaposi’s sarcoma (KS) is a vascular proliferative vascular lesions including KS. In normal tissues, disorder with four epidemiological forms: classic, D2-40 stained the endothelium of lymphatic channels African endemic, iatrogenic transplant related, and but not of blood vessels, including arteries and capil- epidemic acute immune deficiency syndrome laries defined by reactivity with the blood vessel endo- (AIDS) related (1). KS is usually limited to the skin thelial marker PAL-E. In our series of vascular lesions, but may involve mucus membranes, visceral or- D2-40 stained lymphangiomas (10/10), benign tumors gans, and lymph nodes in the more aggressive of undisputed lymphatic origin, but not benign neo- forms (2). For cutaneous KS, a histopathological plasms or tumorlike lesions of blood vessel origin, progression from patch to plaque and nodular including hemangiomas (0/10), glomus tumors (0/3), stages correlates with a clinical progression from angiolipomas (0/2), pyogenic granulomas (0/2), vascu- macules to palpable tumors (2). The patch stage is lar malformations (0/2), hemangiopericytoma (0/1), characterized by networks of thin-walled irregular or hemangioendothelioma (0/1). D2-40 stained all endothelial-lined spaces; the plaque stage, by cases of cutaneous KS (24/24) at all stages of progres- sparse spindle cells intermingled among irregular sion, including patch, plaque, and nodular stages, endothelial-lined spaces; and the nodular stage, by supporting the concept that this disease originates sheets or fascicles of spindle cells (2). from a cell type capable of undergoing lymphatic dif- Although the exact pathogenesis of KS is not de- ferentiation. D2-40 also stained three of seven angio- fined, it has been suggested that a chronic cytokine- sarcomas, indicating that a subset of these tumors can mediated proliferative state of an endothelial cell, undergo at least partial differentiation along the lym- phatic endothelial lineage and could be classified as possibly triggered by activation of a latent KS- lymphangiosarcomas. In comparison, CD31 was ex- associated herpes virus (KSHV) infection, promotes pressed in all benign and malignant vascular lesions, transformation to a neoplastic cell (1, 3, 4). The origin except for glomus tumors (0/3) and 5/10 lymphangi- of KS from blood vessel or lymphatic endothelium is controversial. Although some early studies failed to detect the presence of blood vessel endothelial mark- ers in KS (5), other studies reported the presence of Copyright © 2002 by The United States and Canadian Academy of Pathology, Inc. traditional blood vessel endothelial markers including VOL. 15, NO. 4, P. 434, 2002 Printed in the U.S.A. CD31, CD34, and von Willebrand factor (vWF, Factor Date of acceptance: December 6, 2001. Address reprint requests to: Harriette J. Kahn, M.D., Department of Pa- VIII–related antigen) (6–9). The latter findings are thology, Sunnybrook and Women’s College Health Sciences Centre, Sun- nybrook Campus, E4-33, 2075 Bayview Avenue, Toronto, Ontario, Can- compatible with a theory of origin of KS from blood ada, M4N 3M5; fax: (416) 480-4271; e-mail: [email protected]. vessel endothelium. However, this interpretation is 434 complicated by recent observations that the above (Hornby, Ontario, Canada). The mAb to CD31 blood vessel endothelial markers are also weakly ex- (Clone JC/70A, hybridoma supernatant) was pur- pressed on lymphatic endothelium (9–11). Further- chased from DAKO (Carpinteria, CA). more, ultrastructural features and the absence of the Sections of paraffin-embedded tissues (5 ␮m) were blood vessel endothelium–specific PAL-E antigen (12) dewaxed through graded concentrations of ethanol. from KS argue against an origin from blood vessel For immunostaining, heat-inducted epitope retrieval endothelial cells (13–15). These considerations have by microwave pretreatment (800 W for 10 min) was led some authors to suggest that KS originates from only performed for CD31. The sections were first in- lymphatic endothelium (5, 14). This notion has been cubated in methanol containing 3% H2O2 to inacti- reinforced recently by the demonstration of a uniform vate endogenous peroxidase. The sections were then expression of two lymphatic endothelial markers, vas- incubated with mAb D2-40 (0.1 ␮g/mL), or anti-CD31 cular endothelial growth factor receptor-3 (VEGFR-3; (1:40 dilution), followed sequentially by biotinylated 16) and podoplanin (17), in KS (18–20). However, goat anti-mouse immunoglobulin (IgG) antibody VEGFR-3 has also been shown to be expressed by (Zymed, San Francisco, CA) at a 1:200 dilution and a neoplastic blood vessel endothelia in both benign and horseradish peroxidase–avidin conjugate (DAKO) at a malignant vascular tumors and, in this situation, loses 1:500 dilution. For color development, the sections its selectivity for lymphatic endothelium (21). There- were incubated with 3,3'-diamino-benzidine. Adja- fore, we wished to reexamine these results with an cent cryostat sections (5 ␮m) of quick-frozen tissues independent marker of lymphatic endothelium. were air-dried and fixed in cold acetone for 10 min. We recently observed that D2-40, a monoclonal After inactivation of the endogenous peroxidase as antibody (mAb) to an Mr 40,000 O-linked sialogly- described above, the sections were immunostained coprotein (22), was a selective marker of lymphatic with mAb PAL-E (0.15 ␮g/mL) or D2-40 (0.1 ␮g/mL), endothelium. In this study, we examined the ex- also as described above. pression of this novel marker of lymphatic endo- thelium in normal tissues and compared its reac- tivity with the expression of CD31 in a series of 62 RESULTS vascular lesions, including 24 cases of cutaneous KS at different stages of progression. Consecutive cryostat sections of human tonsil were stained with mAb D2-40 or PAL-E (that is specific for endothelial cells of blood vessels; 12). MATERIALS AND METHODS These antibodies stained nonoverlapping popula- tions of thin-walled endothelial channels in adja- Formalin-fixed, paraffin-embedded blocks of cent sections. PAL-E stained blood vessels (Fig. 1A, normal tissue, 62 vascular lesions (24 cutaneous KS, arrowheads) that did not stain with D2-40 (Fig. 1B). 7 angiosarcomas, 10 lymphangiomas, 10 hemangi- Conversely, D2-40 stained lymphatic channels (Fig. omas, 3 glomus tumors, 2 angiolipomas, 2 pyogenic 1B, arrowheads) that did not stain with PAL-E (Fig. granulomas, 2 vascular malformations, 1 heman- 1A). In paraffin sections of normal breast, D2-40 giopericytoma, 1 hemangioendothelioma), 28 non- stained the endothelium of lymphatic channels vascular soft-tissue tumors (10 leiomyosarcomas, 6 (Fig. 1C, arrowheads), but not the endothelium of neurofibromas, 6 dermatofibromas, 4 dermatofi- an artery in a vascular bundle (Fig. 1C, arrow). brosarcoma protuberans, 2 malignant fibrous histi- D2-40 also stained the endothelium of a lym- ocytomas), as well as frozen samples of tonsil, were phatic channel containing lymphocytes (Fig. 1D, obtained from the Department of Pathology, Sun- arrowhead), but not the adjacent capillary (Fig. 1D, nybrook and Women’s College Health Sciences arrow). The results of immunostaining of a series of Center, University of Toronto, Ontario, Canada. vascular lesions with mAb D2-40 and for CD31 are The KS specimens included patch, plaque, and summarized in Table 1. D2-40 reacted strongly with nodular lesions from patients with classic and all cases of cutaneous KS (24/24) at the patch (Fig. AIDS- and transplant-related KS. None of the an- 2B–C), plaque, and nodular (Fig. 2E–F) stages of giosarcomas were associated with lymphedema or progression. D2-40 also reacted with the endothe- preexisting lymphangioma. lium lining the sinusoidal spaces in all lymphangi- MAb D2-40 (IgG1) was purified from mouse as- omas (10/10; Fig. 3A) but did not react with any citic fluid, as previously described (22), and stored hemangiomas (0/10), glomus tumors (0/3), angio- at a concentration of 0.7 mg/mL under sterile con- lipomas (0/2), pyogenic granulomas (0/2), vascular ditions at 4° C. The mAb to an undefined blood malformations (0/2), hemangiopericytoma (0/1), or vessel endothelial antigen, clone PAL-E, (hybrid-
Load more

Recommended publications
  • Soft Tissue Cytopathology: a Practical Approach Liron Pantanowitz, MD
    4/1/2020 Soft Tissue Cytopathology: A Practical Approach Liron Pantanowitz, MD Department of Pathology University of Pittsburgh Medical Center [email protected] What does the clinician want to know? • Is the lesion of mesenchymal origin or not? • Is it begin or malignant? • If it is malignant: – Is it a small round cell tumor & if so what type? – Is this soft tissue neoplasm of low or high‐grade? Practical diagnostic categories used in soft tissue cytopathology 1 4/1/2020 Practical approach to interpret FNA of soft tissue lesions involves: 1. Predominant cell type present 2. Background pattern recognition Cell Type Stroma • Lipomatous • Myxoid • Spindle cells • Other • Giant cells • Round cells • Epithelioid • Pleomorphic Lipomatous Spindle cell Small round cell Fibrolipoma Leiomyosarcoma Ewing sarcoma Myxoid Epithelioid Pleomorphic Myxoid sarcoma Clear cell sarcoma Pleomorphic sarcoma 2 4/1/2020 CASE #1 • 45yr Man • Thigh mass (fatty) • CNB with TP (DQ stain) DQ Mag 20x ALT –Floret cells 3 4/1/2020 Adipocytic Lesions • Lipoma ‐ most common soft tissue neoplasm • Liposarcoma ‐ most common adult soft tissue sarcoma • Benign features: – Large, univacuolated adipocytes of uniform size – Small, bland nuclei without atypia • Malignant features: – Lipoblasts, pleomorphic giant cells or round cells – Vascular myxoid stroma • Pitfalls: Lipophages & pseudo‐lipoblasts • Fat easily destroyed (oil globules) & lost with preparation Lipoma & Variants . Angiolipoma (prominent vessels) . Myolipoma (smooth muscle) . Angiomyolipoma (vessels + smooth muscle) . Myelolipoma (hematopoietic elements) . Chondroid lipoma (chondromyxoid matrix) . Spindle cell lipoma (CD34+ spindle cells) . Pleomorphic lipoma . Intramuscular lipoma Lipoma 4 4/1/2020 Angiolipoma Myelolipoma Lipoblasts • Typically multivacuolated • Can be monovacuolated • Hyperchromatic nuclei • Irregular (scalloped) nuclei • Nucleoli not typically seen 5 4/1/2020 WD liposarcoma Layfield et al.
    [Show full text]
  • Tumors and Tumor-Like Lesions of Blood Vessels 16 F.Ramon
    16_DeSchepper_Tumors_and 15.09.2005 13:27 Uhr Seite 263 Chapter Tumors and Tumor-like Lesions of Blood Vessels 16 F.Ramon Contents 42]. There are two major classification schemes for vas- cular tumors. That of Enzinger et al. [12] relies on 16.1 Introduction . 263 pathological criteria and includes clinical and radiolog- 16.2 Definition and Classification . 264 ical features when appropriate. On the other hand, the 16.2.1 Benign Vascular Tumors . 264 classification of Mulliken and Glowacki [42] is based on 16.2.1.1 Classification of Mulliken . 264 endothelial growth characteristics and distinguishes 16.2.1.2 Classification of Enzinger . 264 16.2.1.3 WHO Classification . 265 hemangiomas from vascular malformations. The latter 16.2.2 Vascular Tumors of Borderline classification shows good correlation with the clinical or Intermediate Malignancy . 265 picture and imaging findings. 16.2.3 Malignant Vascular Tumors . 265 Hemangiomas are characterized by a phase of prolif- 16.2.4 Glomus Tumor . 266 eration and a stationary period, followed by involution. 16.2.5 Hemangiopericytoma . 266 Vascular malformations are no real tumors and can be 16.3 Incidence and Clinical Behavior . 266 divided into low- or high-flow lesions [65]. 16.3.1 Benign Vascular Tumors . 266 Cutaneous and subcutaneous lesions are usually 16.3.2 Angiomatous Syndromes . 267 easily diagnosed and present no significant diagnostic 16.3.3 Hemangioendothelioma . 267 problems. On the other hand, hemangiomas or vascular 16.3.4 Angiosarcomas . 268 16.3.5 Glomus Tumor . 268 malformations that arise in deep soft tissue must be dif- 16.3.6 Hemangiopericytoma .
    [Show full text]
  • The Health-Related Quality of Life of Sarcoma Patients and Survivors In
    Cancers 2020, 12 S1 of S7 Supplementary Materials The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of A Nationwide Observational Study (PROSa) Martin Eichler, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, Jens Jakob, Susanne Singer, Robert Grützmann, Stephen Fung, Eva Wardelmann, Karin Arndt, Vitali Heidt, Christine Hofbauer, Marius Fried, Verena I. Gaidzik, Karl Verpoort, Marit Ahrens, Jürgen Weitz, Klaus-Dieter Schaser, Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler and the PROSa study group Includes Entities We included sarcomas according to the following WHO classification. - Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. 468 p. (World Health Organization classification of tumours). - Kurman RJ, International Agency for Research on Cancer, World Health Organization, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. 307 p. (World Health Organization classification of tumours). - Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. Eur Urol. 2016 Jul;70(1):106–19. - World Health Organization, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed.
    [Show full text]
  • Appendix 4 WHO Classification of Soft Tissue Tumours17
    S3.02 The histological type and subtype of the tumour must be documented wherever possible. CS3.02a Accepting the limitations of sampling and with the use of diagnostic common sense, tumour type should be assigned according to the WHO system 17, wherever possible. (See Appendix 4 for full list). CS3.02b If precise tumour typing is not possible, generic descriptions to describe the tumour may be useful (eg myxoid, pleomorphic, spindle cell, round cell etc), together with the growth pattern (eg fascicular, sheet-like, storiform etc). (See G3.01). CS3.02c If the reporting pathologist is unfamiliar or lacks confidence with the myriad possible diagnoses, then at this point a decision to send the case away without delay for an expert opinion would be the most sensible option. Referral to the pathologist at the nearest Regional Sarcoma Service would be appropriate in the first instance. Further International Pathology Review may then be obtained by the treating Regional Sarcoma Multidisciplinary Team if required. Adequate review will require submission of full clinical and imaging information as well as histological sections and paraffin block material. Appendix 4 WHO classification of soft tissue tumours17 ADIPOCYTIC TUMOURS Benign Lipoma 8850/0* Lipomatosis 8850/0 Lipomatosis of nerve 8850/0 Lipoblastoma / Lipoblastomatosis 8881/0 Angiolipoma 8861/0 Myolipoma 8890/0 Chondroid lipoma 8862/0 Extrarenal angiomyolipoma 8860/0 Extra-adrenal myelolipoma 8870/0 Spindle cell/ 8857/0 Pleomorphic lipoma 8854/0 Hibernoma 8880/0 Intermediate (locally
    [Show full text]
  • Solitary Noninfiltrating Angiolipoma on the Finger, an Unusual Localization
    Volume 25 Number 2| February 2019| Dermatology Online Journal || Case Presentation 24(2): 8 Solitary noninfiltrating angiolipoma on the finger, an unusual localization. 1 1 1 2 3 Muge Gore Karaali , Asude Kara Polat , Ayse Esra Koku Aksu , Cem Leblebici , Mehmet Salih Gurel Affiliations: Department of Dermatology, Health and Science University Istanbul Training and Research Hospital, Istanbul, Turkey, 2Department of Pathology, Health and Science University Istanbul Training and Research Hospital, Istanbul, Turkey, 3Department of Dermatology, Medeniyet University, Göztepe Training and Research Hospital, Istanbul, Turkey Corresponding Author: Muge Gore Karaali MD, Istanbul Training and Research Hospital, Department of Dermatology, PK: 34098, Istanbul, Turkey, Tel: 90 530 3093328, Fax: 90 212 6320060, Email: [email protected] [2, 3]. A presumptive diagnosis may be via Abstract ultrasonography and/or magnetic resonance Angiolipoma, a subtype of lipoma, is a benign imaging (MRI), [4]. Its definitive diagnosis may be adypocytic soft tissue tumor composed of mature made by clinical examination. Histologically, one adipose tissue and small vascular proliferations. This observes an encapsulated tumor (noninfiltrative) entity makes up 5–17% of all lipomas. The diagnosis and rarely an infiltrative form [5]. The most common is made by clinical and pathological examination, treatment option for this tumor is surgical excision. ultrasonography, and/or magnetic resonance Recurrence has been reported for infiltrating type of imaging (MRI). It is generally an encapsulated tumor (noninfiltrative), but rarely has an infiltrative form. angiolipomas. Noninfiltrating forms generally do not Angiolipoma mostly occurs on the trunk and recur after excision [3]. The forearm is the most extremities with male predominance. The forearm is frequent localization for angiolipomas [1].
    [Show full text]
  • Glomus Tumor in the Floor of the Mouth: a Case Report and Review of the Literature Haixiao Zou1,2, Li Song1, Mengqi Jia2,3, Li Wang4 and Yanfang Sun2,3*
    Zou et al. World Journal of Surgical Oncology (2018) 16:201 https://doi.org/10.1186/s12957-018-1503-6 CASEREPORT Open Access Glomus tumor in the floor of the mouth: a case report and review of the literature Haixiao Zou1,2, Li Song1, Mengqi Jia2,3, Li Wang4 and Yanfang Sun2,3* Abstract Background: Glomus tumors are rare benign neoplasms that usually occur in the upper and lower extremities. Oral cavity involvement is exceptionally rare, with only a few cases reported to date. Case presentation: A 24-year-old woman with complaints of swelling in the left floor of her mouth for 6 months was referred to our institution. Her swallowing function was slightly affected; however, she did not have pain or tongue paralysis. Enhanced computed tomography revealed a 2.8 × 1.8 × 2.1 cm-sized well-defined, solid, heterogeneous nodule above the mylohyoid muscle. The mandible appeared to be uninvolved. The patient underwent surgery via an intraoral approach; histopathological examination revealed a glomus tumor. The patient has had no evidence of recurrence over 4 years of follow-up. Conclusions: Glomus tumors should be considered when patients present with painless nodules in the floor of the mouth. Keywords: Glomus tumor, Floor of mouth, Oral surgery Background Case presentation Theglomusbodyisaspecialarteriovenousanasto- A 24-year-old woman with a 6-month history of swelling mosisandfunctionsinthermalregulation.Glomustu- in the left floor of her mouth was referred to our institu- mors are rare, benign, mesenchymal tumors that tion. Although she experienced slight difficulty in swal- originate from modified smooth muscle cells of the lowing, she did not experience pain or tongue paralysis.
    [Show full text]
  • Benign Hemangiomas
    TUMORS OF BLOOD VESSELS CHARLES F. GESCHICKTER, M.D. (From tke Surgical Palkological Laboratory, Department of Surgery, Johns Hopkins Hospital and University) AND LOUISA E. KEASBEY, M.D. (Lancaster Gcaeral Hospital, Lancuster, Pennsylvania) Tumors of the blood vessels are perhaps as common as any form of neoplasm occurring in the human body. The greatest number of these lesions are benign angiomas of the body surfaces, small elevated red areas which remain without symptoms throughout life and are not subjected to treatment. Larger tumors of this type which undergb active growth after birth or which are situated about the face or oral cavity, where they constitute cosmetic defects, are more often the object of surgical removal. The majority of the vascular tumors clinically or pathologically studied fall into this latter group. Benign angiomas of similar pathologic nature occur in all of the internal viscera but are most common in the liver, where they are disclosed usually at autopsy. Angiomas of the bone, muscle, and the central nervous system are of less common occurrence, but, because of the symptoms produced, a higher percentage are available for study. Malignant lesions of the blood vessels are far more rare than was formerly supposed. An occasional angioma may metastasize following trauma or after repeated recurrences, but less than 1per cent of benign angiomas subjected to treatment fall into this group. I Primarily ma- lignant tumors of the vascular system-angiosarcomas-are equally rare. The pathological criteria for these growths have never been ade- quately established, and there is no general agreement as to this par- ticular form of tumor.
    [Show full text]
  • Subcutaneous Cavernous and Capillary Hemangiomas of the Breast: Radiologic-Pathological Correlation1 유방의 피하지방층에 발생한 해면 혈관종과 모세 혈관종:영상 및 병리 소견의 비교1
    Case Report pISSN 1738-2637 / eISSN 2288-2928 J Korean Soc Radiol 2013;69(6):475-479 http://dx.doi.org/10.3348/jksr.2013.69.6.475 Subcutaneous Cavernous and Capillary Hemangiomas of the Breast: Radiologic-Pathological Correlation1 유방의 피하지방층에 발생한 해면 혈관종과 모세 혈관종:영상 및 병리 소견의 비교1 Hyoung Nam Lee, MD1, Shin Young Kim, MD1, Hyung Hwan Kim, MD1, Hyun-Deuk Cho, MD2 Departments of 1Radiology, 2Pathology, Soonchunhyang University Cheonan Hospital, Cheonan, Korea Vascular tumors of the breast are uncommon and include hemangioma, angiolipo- ma, and angiosarcoma. Among breast hemangiomas, capillary hemangiomas are Received June 28, 2013; Accepted October 16, 2013 relatively rare in contrast to cavernous hemangiomas. We report two rare cases of Corresponding author: Shin Young Kim, MD Department of Radiology, Soonchunhyang University cavernous and capillary hemangiomas of the breast by mammography, sonography, Cheonan Hospital, 31 Suncheonhyang 6-gil, and positron emission tomography/computed tomography. Dongnam-gu, Cheonan 330-721, Korea. Tel. 82-41-570-3515 Fax. 82-41-579-9026 E-mail: [email protected] Index terms Breast This is an Open Access article distributed under the terms Hemangioma of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) Mammography which permits unrestricted non-commercial use, distri- Sonography bution, and reproduction in any medium, provided the Positron Emission Tomography/CT original work is properly cited. INTRODUCTION CASE REPORT Benign hemangiomas of the breast are rare. The mammo- Case 1 graphic and sonographic appearance of breast hemangiomas An 80-year-old woman had a 6-month history of a palpable have been described in several reports (1-4) but only a few re- mass in the left breast.
    [Show full text]
  • 8.5 X12.5 Doublelines.P65
    Cambridge University Press 978-0-521-87409-0 - Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions Edited by Markku Miettinen Index More information Index abdominal ependymoma, 744 mucinous cystadenocarcinoma, 631 adult fibrosarcoma (AF), 364–365, 1026 abdominal extrauterine smooth muscle ovarian adenocarcinoma, 72, 79 adult granulosa cell tumor, 523–524 tumors, 79 pancreatic adenocarcinoma, 846 clinical features, 523 abdominal inflammatory myofibroblastic pulmonary adenocarcinoma, 51 genetics, 524 tumors, 297–298 renal adenocarcinoma, 67 pathology, 523–524 abdominal leiomyoma, 467, 477 serous cystadenocarcinoma, 631 adult rhabdomyoma, 548–549 abdominal leiomyosarcoma. See urinary bladder/urogenital tract clinical features, 548 gastrointestinal stromal tumor adenocarcinoma, 72, 401 differential diagnosis, 549 (GIST) uterine adenocarcinomas, 72 genetics, 549 abdominal perivascular epithelioid cell tumors adenofibroma, 523 pathology, 548–549 (PEComas), 542 adenoid cystic carcinoma, 1035 aggressive angiomyxoma (AAM), 514–518 abdominal wall desmoids, 244 adenomatoid tumor, 811–813 clinical features, 514–516 acquired elastotic hemangioma, 598 adenomatous polyposis coli (APC) gene, 143 differential diagnosis, 518 acquired tufted angioma, 590 adenosarcoma (mullerian¨ adenosarcoma), 523 genetics, 518 acral arteriovenous tumor, 583 adipocytic lesions (cytology), 1017–1022 pathology, 516 acral myxoinflammatory fibroblastic sarcoma atypical lipomatous tumor/well- aggressive digital papillary adenocarcinoma, (AMIFS), 365–370, 1026 differentiated
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • Histopathological Study of Vascular Lesions
    IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 16, Issue 11 Ver. I (Nov. 2017), PP 47-52 www.iosrjournals.org Histopathological Study of Vascular Lesions 1Dr. D. Kalyani, 2*Dr. N.Bharatarao, 1Associate Professor,Department of Pathology, Siddhartha Medical College,Vijayawada 2Professor & HOD,Department of Pathology, Siddhartha Medical College,Vijayawada Corresponding Author: *Dr. N. Bharatarao Abstract Background: Vascular lesions show a broad variety of morphological appearances and cilinical behavior, the lesions are ranging from inflammatory, benign hemangiomas to intermediate lesion, which are locally aggressive, to highly malignant angiosarcoma. There is also the grey zone between true neoplasia and hamartoma, which makes difficulty in histopathological assessment. It is also important to decide the degree of malignancy as it can strongly influence the choice of treatment and prognosis. Materials and Methods: 98 cases of vascular lesions at the department of pathology, Siddharda medical college, Vijayawada,for a period of three years(2014 -2016) have been studied retrospectivelyand histopathological features were analyzed. Results:A total of 98 vascular lesions were identified. Thsese were classified into inflammatory and neoplastic. The neoplastic tumors are subclassified into benign, intermediate and malignant according to WHO classification. The various vascular lesions identified were Leucocytoclastic vasculitis, Small vessel vasculitis, Granulomapyogenicum,Capillary hemangiomas, Cavernous hemangiomas,AV malformation, Sclerosing hemangiomas, Verrucous hemangioma, Intramuscular hemangioma, Hemangioblastoma, Angiokeratoma, Hemangioendothelioma, Epithelioidhemangioendotheliomama, Angiosarcoma,Epithelioid Angiosarcoma and Glomus tumor (Perivascular tumour). Majority of vascular tumors were benign, more common in children and young adults, most common sites were head and neck, which required only local surgical excision.
    [Show full text]
  • Table of Contents
    CONTENTS 1. Specimen evaluation 1 Specimen Type. 1 Clinical History. 1 Radiologic Correlation . 1 Special Studies . 1 Immunohistochemistry . 2 Electron Microscopy. 2 Genetics. 3 Recognizing Non-Soft Tissue Tumors. 3 Grading and Prognostication of Sarcomas. 3 Management of Specimen and Reporting. 4 2. Nonmalignant Fibroblastic and Myofibroblastic Tumors and Tumor-Like Lesions . 7 Nodular Fasciitis . 7 Proliferative Fasciitis and Myositis . 12 Ischemic Fasciitis . 18 Fibroma of Tendon Sheath. 21 Nuchal-Type Fibroma . 24 Gardner-Associated Fibroma. 27 Desmoplastic Fibroblastoma. 27 Elastofibroma. 34 Pleomorphic Fibroma of Skin. 39 Intranodal (Palisaded) Myofibroblastoma. 39 Other Fibroma Variants and Fibrous Proliferations . 44 Calcifying Fibrous (Pseudo)Tumor . 47 Juvenile Hyaline Fibromatosis. 52 Fibromatosis Colli. 54 Infantile Digital Fibroma/Fibromatosis. 58 Calcifying Aponeurotic Fibroma. 63 Fibrous Hamartoma of Infancy . 65 Myofibroma/Myofibromatosis . 69 Palmar/Plantar Fibromatosis. 80 Lipofibromatosis. 85 Diffuse Infantile Fibromatosis. 90 Desmoid-Type Fibromatosis . 92 Benign Fibrous Histiocytoma (Dermatofibroma). 98 xi Tumors of the Soft Tissues Non-neural Granular Cell Tumor. 104 Neurothekeoma . 104 Plexiform Fibrohistiocytic Tumor. 110 Superficial Acral Fibromyxoma . 113 Superficial Angiomyxoma (Cutaneous Myxoma). 118 Intramuscular Myxoma. 125 Juxta-articular Myxoma. 128 Aggressive Angiomyxoma . 128 Angiomyofibroblastoma. 135 Cellular Angiofibroma. 136 3. Fibroblastic/Myofibroblastic Neoplasms with Variable Biologic Potential.
    [Show full text]